Keros Therapeutics Report issue

For profit Phase 2
Founded: Lexington Massachusetts United States (2015)

Organization Overview

First Clinical Trial
2020
NCT04419649
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Alternative names

Keros Therapeutics | Keros Therapeutics, Inc.